# PeptideScanner evidence objects: GHRP-2

Every published version of the records placed with GHRP-2, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json. Selected public evidence only; not medical advice.

- Objects: 21
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="pubmed-pmid-10195374-ghrp-2-v1"></a>

## Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.

> PubMed lists PMID 10195374 in Journal of endocrinological investigation as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1999-02 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-10195374-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-11-13
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-10195374-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-10195374-ghrp-2-v1
- Content SHA-256: `dc9680ade3d2f06a388ab0edae9f41a1b0d2e9856797ef199989e3fc2cb6d3e1`

### Claims and source pins

#### Headline

Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. ([`pubmed-observation-pmid-10195374-2018-11-13-6acd0535fb5d`](#source-pubmed-observation-pmid-10195374-2018-11-13-6acd0535fb5d))

#### Summary

PubMed lists PMID 10195374 in Journal of endocrinological investigation as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1999-02 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-10195374-2018-11-13-6acd0535fb5d`](#source-pubmed-observation-pmid-10195374-2018-11-13-6acd0535fb5d))

#### Paragraph 1

PubMed lists PMID 10195374 in Journal of endocrinological investigation as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1999-02 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-10195374-2018-11-13-6acd0535fb5d`](#source-pubmed-observation-pmid-10195374-2018-11-13-6acd0535fb5d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-10195374-2018-11-13-6acd0535fb5d`](#source-pubmed-observation-pmid-10195374-2018-11-13-6acd0535fb5d))

### Sources

<a id="source-pubmed-observation-pmid-10195374-2018-11-13-6acd0535fb5d"></a>
- **Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. · retained source version 1:2018-11-13:current:6acd0535fb5d913707848ea8b91b8b4e1cba735f00367e59419ec1068be86c07** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/10195374/) (`pubmed-observation-pmid-10195374-2018-11-13-6acd0535fb5d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-10195374-ghrp-2-v1 SHA-256: dc9680ade3d2f06a388ab0edae9f41a1b0d2e9856797ef199989e3fc2cb6d3e1.

---

<a id="pubmed-pmid-15230633-ghrp-2-v1"></a>

## Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN.

> PubMed lists PMID 15230633 in Drugs in R&D as Journal Article, Review, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-15230633-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-10-25
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-15230633-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-15230633-ghrp-2-v1
- Content SHA-256: `bfe256ba1a2e2f65515293215096bce354f1dbccc76534dc87191ce604dfd08d`

### Claims and source pins

#### Headline

Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN. ([`pubmed-observation-pmid-15230633-2018-10-25-cb925afc1222`](#source-pubmed-observation-pmid-15230633-2018-10-25-cb925afc1222))

#### Summary

PubMed lists PMID 15230633 in Drugs in R&D as Journal Article, Review, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15230633-2018-10-25-cb925afc1222`](#source-pubmed-observation-pmid-15230633-2018-10-25-cb925afc1222))

#### Paragraph 1

PubMed lists PMID 15230633 in Drugs in R&D as Journal Article, Review, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15230633-2018-10-25-cb925afc1222`](#source-pubmed-observation-pmid-15230633-2018-10-25-cb925afc1222))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-15230633-2018-10-25-cb925afc1222`](#source-pubmed-observation-pmid-15230633-2018-10-25-cb925afc1222))

### Sources

<a id="source-pubmed-observation-pmid-15230633-2018-10-25-cb925afc1222"></a>
- **Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN. · retained source version 1:2018-10-25:current:cb925afc1222f2e772dd0733802c4e71ae519a0aec6ac20d1003478df32c7773** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/15230633/) (`pubmed-observation-pmid-15230633-2018-10-25-cb925afc1222`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-15230633-ghrp-2-v1 SHA-256: bfe256ba1a2e2f65515293215096bce354f1dbccc76534dc87191ce604dfd08d.

---

<a id="pubmed-pmid-15646370-ghrp-2-v1"></a>

## Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.

> PubMed lists PMID 15646370 in Arzneimittel-Forschung as Journal Article, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-15646370-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-11-24
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-15646370-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-15646370-ghrp-2-v1
- Content SHA-256: `a63ca8d42e677f66685ad7e319165032b7b07ee908356040a269c76439cdc4ae`

### Claims and source pins

#### Headline

Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. ([`pubmed-observation-pmid-15646370-2016-11-24-8767112dcd6e`](#source-pubmed-observation-pmid-15646370-2016-11-24-8767112dcd6e))

#### Summary

PubMed lists PMID 15646370 in Arzneimittel-Forschung as Journal Article, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15646370-2016-11-24-8767112dcd6e`](#source-pubmed-observation-pmid-15646370-2016-11-24-8767112dcd6e))

#### Paragraph 1

PubMed lists PMID 15646370 in Arzneimittel-Forschung as Journal Article, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15646370-2016-11-24-8767112dcd6e`](#source-pubmed-observation-pmid-15646370-2016-11-24-8767112dcd6e))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-15646370-2016-11-24-8767112dcd6e`](#source-pubmed-observation-pmid-15646370-2016-11-24-8767112dcd6e))

### Sources

<a id="source-pubmed-observation-pmid-15646370-2016-11-24-8767112dcd6e"></a>
- **Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. · retained source version 1:2016-11-24:current:8767112dcd6ea02ea892946b85c5e9c2d8c9409aabe48adb8ea011dbb0f22b77** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/15646370/) (`pubmed-observation-pmid-15646370-2016-11-24-8767112dcd6e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-15646370-ghrp-2-v1 SHA-256: a63ca8d42e677f66685ad7e319165032b7b07ee908356040a269c76439cdc4ae.

---

<a id="pubmed-pmid-15646371-ghrp-2-v1"></a>

## General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.

> PubMed lists PMID 15646371 in Arzneimittel-Forschung as Journal Article, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-15646371-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-11-24
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-15646371-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-15646371-ghrp-2-v1
- Content SHA-256: `86d08d980757d1a7d0b9bd56166643e895688c9f23075640c738187c731cdbe3`

### Claims and source pins

#### Headline

General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. ([`pubmed-observation-pmid-15646371-2016-11-24-cabe956b6f71`](#source-pubmed-observation-pmid-15646371-2016-11-24-cabe956b6f71))

#### Summary

PubMed lists PMID 15646371 in Arzneimittel-Forschung as Journal Article, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15646371-2016-11-24-cabe956b6f71`](#source-pubmed-observation-pmid-15646371-2016-11-24-cabe956b6f71))

#### Paragraph 1

PubMed lists PMID 15646371 in Arzneimittel-Forschung as Journal Article, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15646371-2016-11-24-cabe956b6f71`](#source-pubmed-observation-pmid-15646371-2016-11-24-cabe956b6f71))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-15646371-2016-11-24-cabe956b6f71`](#source-pubmed-observation-pmid-15646371-2016-11-24-cabe956b6f71))

### Sources

<a id="source-pubmed-observation-pmid-15646371-2016-11-24-cabe956b6f71"></a>
- **General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. · retained source version 1:2016-11-24:current:cabe956b6f715b645a6742552e38f399b337521107816fad8093c834c042fe87** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/15646371/) (`pubmed-observation-pmid-15646371-2016-11-24-cabe956b6f71`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-15646371-ghrp-2-v1 SHA-256: 86d08d980757d1a7d0b9bd56166643e895688c9f23075640c738187c731cdbe3.

---

<a id="pubmed-pmid-16033952-ghrp-2-v1"></a>

## Physiologically based pharmacokinetic model for pralmorelin hydrochloride in rats.

> PubMed lists PMID 16033952 in Drug metabolism and disposition: the biological fate of chemicals as Journal Article, with publication-date metadata of 2005-07-20 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-16033952-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-02-12
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-16033952-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-16033952-ghrp-2-v1
- Content SHA-256: `1250fe0d23b4d0e6acd3a38bf38c53b3cc96010e11368f893efea3c1772c45d3`

### Claims and source pins

#### Headline

Physiologically based pharmacokinetic model for pralmorelin hydrochloride in rats. ([`pubmed-observation-pmid-16033952-2025-02-12-355191940fe9`](#source-pubmed-observation-pmid-16033952-2025-02-12-355191940fe9))

#### Summary

PubMed lists PMID 16033952 in Drug metabolism and disposition: the biological fate of chemicals as Journal Article, with publication-date metadata of 2005-07-20 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-16033952-2025-02-12-355191940fe9`](#source-pubmed-observation-pmid-16033952-2025-02-12-355191940fe9))

#### Paragraph 1

PubMed lists PMID 16033952 in Drug metabolism and disposition: the biological fate of chemicals as Journal Article, with publication-date metadata of 2005-07-20 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-16033952-2025-02-12-355191940fe9`](#source-pubmed-observation-pmid-16033952-2025-02-12-355191940fe9))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-16033952-2025-02-12-355191940fe9`](#source-pubmed-observation-pmid-16033952-2025-02-12-355191940fe9))

### Sources

<a id="source-pubmed-observation-pmid-16033952-2025-02-12-355191940fe9"></a>
- **Physiologically based pharmacokinetic model for pralmorelin hydrochloride in rats. · retained source version 1:2025-02-12:current:355191940fe964dca114595a612f69c5ae39d216412752bc659e1a4f5f026e0b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/16033952/) (`pubmed-observation-pmid-16033952-2025-02-12-355191940fe9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Physiologically based pharmacokinetic model for pralmorelin hydrochloride in rats." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-16033952-ghrp-2-v1 SHA-256: 1250fe0d23b4d0e6acd3a38bf38c53b3cc96010e11368f893efea3c1772c45d3.

---

<a id="pubmed-pmid-17971793-ghrp-2-v1"></a>

## Validation of growth-hormone-releasing peptide 2 for the diagnosis of adult growth hormone deficiency.

> PubMed lists PMID 17971793 in Nature clinical practice. Endocrinology & metabolism as Journal Article, with publication-date metadata of 2007-10-30 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-17971793-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2008-01-23
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-17971793-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-17971793-ghrp-2-v1
- Content SHA-256: `f1ed5c8b3f44434509df336a9ece6e85bc29289bec9680889d8966b20ce46284`

### Claims and source pins

#### Headline

Validation of growth-hormone-releasing peptide 2 for the diagnosis of adult growth hormone deficiency. ([`pubmed-observation-pmid-17971793-2008-01-23-969f043bddff`](#source-pubmed-observation-pmid-17971793-2008-01-23-969f043bddff))

#### Summary

PubMed lists PMID 17971793 in Nature clinical practice. Endocrinology & metabolism as Journal Article, with publication-date metadata of 2007-10-30 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17971793-2008-01-23-969f043bddff`](#source-pubmed-observation-pmid-17971793-2008-01-23-969f043bddff))

#### Paragraph 1

PubMed lists PMID 17971793 in Nature clinical practice. Endocrinology & metabolism as Journal Article, with publication-date metadata of 2007-10-30 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17971793-2008-01-23-969f043bddff`](#source-pubmed-observation-pmid-17971793-2008-01-23-969f043bddff))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-17971793-2008-01-23-969f043bddff`](#source-pubmed-observation-pmid-17971793-2008-01-23-969f043bddff))

### Sources

<a id="source-pubmed-observation-pmid-17971793-2008-01-23-969f043bddff"></a>
- **Validation of growth-hormone-releasing peptide 2 for the diagnosis of adult growth hormone deficiency. · retained source version 1:2008-01-23:current:969f043bddff6a606f88abba2a7ccb5802e664ce43155f0616fc8669b957163e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/17971793/) (`pubmed-observation-pmid-17971793-2008-01-23-969f043bddff`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Validation of growth-hormone-releasing peptide 2 for the diagnosis of adult growth hormone deficiency." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-17971793-ghrp-2-v1 SHA-256: f1ed5c8b3f44434509df336a9ece6e85bc29289bec9680889d8966b20ce46284.

---

<a id="pubmed-pmid-18493103-ghrp-2-v1"></a>

## Diagnostic usefulness of the growth hormone-releasing peptide-2 test as a substitute for the insulin tolerance test in hypopituitarism.

> PubMed lists PMID 18493103 in Endocrine journal as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-05-21 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-18493103-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-09-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-18493103-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-18493103-ghrp-2-v1
- Content SHA-256: `f93891678bb46eda8756b684c8ae257498fe0422f1d7693002ae9fa2c18e5147`

### Claims and source pins

#### Headline

Diagnostic usefulness of the growth hormone-releasing peptide-2 test as a substitute for the insulin tolerance test in hypopituitarism. ([`pubmed-observation-pmid-18493103-2019-09-07-25f38b04202d`](#source-pubmed-observation-pmid-18493103-2019-09-07-25f38b04202d))

#### Summary

PubMed lists PMID 18493103 in Endocrine journal as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-05-21 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-18493103-2019-09-07-25f38b04202d`](#source-pubmed-observation-pmid-18493103-2019-09-07-25f38b04202d))

#### Paragraph 1

PubMed lists PMID 18493103 in Endocrine journal as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-05-21 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-18493103-2019-09-07-25f38b04202d`](#source-pubmed-observation-pmid-18493103-2019-09-07-25f38b04202d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-18493103-2019-09-07-25f38b04202d`](#source-pubmed-observation-pmid-18493103-2019-09-07-25f38b04202d))

### Sources

<a id="source-pubmed-observation-pmid-18493103-2019-09-07-25f38b04202d"></a>
- **Diagnostic usefulness of the growth hormone-releasing peptide-2 test as a substitute for the insulin tolerance test in hypopituitarism. · retained source version 1:2019-09-07:current:25f38b04202d95c113234cda65f2ad948658c818b8df77571abb75cf8aa226e9** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/18493103/) (`pubmed-observation-pmid-18493103-2019-09-07-25f38b04202d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Diagnostic usefulness of the growth hormone-releasing peptide-2 test as a substitute for the insulin tolerance test in hypopituitarism." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-18493103-ghrp-2-v1 SHA-256: f93891678bb46eda8756b684c8ae257498fe0422f1d7693002ae9fa2c18e5147.

---

<a id="pubmed-pmid-20045717-ghrp-2-v1"></a>

## Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.

> PubMed lists PMID 20045717 in Peptides as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-01-05 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-20045717-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-03-21
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-20045717-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-20045717-ghrp-2-v1
- Content SHA-256: `22045d5644181e931ee82436db48aa3245ffec79f8b1adb79070799ce84578c9`

### Claims and source pins

#### Headline

Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study. ([`pubmed-observation-pmid-20045717-2022-03-21-f5f5ad96d1d4`](#source-pubmed-observation-pmid-20045717-2022-03-21-f5f5ad96d1d4))

#### Summary

PubMed lists PMID 20045717 in Peptides as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-01-05 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20045717-2022-03-21-f5f5ad96d1d4`](#source-pubmed-observation-pmid-20045717-2022-03-21-f5f5ad96d1d4))

#### Paragraph 1

PubMed lists PMID 20045717 in Peptides as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-01-05 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20045717-2022-03-21-f5f5ad96d1d4`](#source-pubmed-observation-pmid-20045717-2022-03-21-f5f5ad96d1d4))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-20045717-2022-03-21-f5f5ad96d1d4`](#source-pubmed-observation-pmid-20045717-2022-03-21-f5f5ad96d1d4))

### Sources

<a id="source-pubmed-observation-pmid-20045717-2022-03-21-f5f5ad96d1d4"></a>
- **Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study. · retained source version 1:2022-03-21:current:f5f5ad96d1d477b61e056cb96cd064d3015ebd46fa06928dce75e88b84ec18d3** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/20045717/) (`pubmed-observation-pmid-20045717-2022-03-21-f5f5ad96d1d4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-20045717-ghrp-2-v1 SHA-256: 22045d5644181e931ee82436db48aa3245ffec79f8b1adb79070799ce84578c9.

---

<a id="pubmed-pmid-20552695-ghrp-2-v1"></a>

## Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry.

> PubMed lists PMID 20552695 in Rapid communications in mass spectrometry : RCM as Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-07-30 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-20552695-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-12-10
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-20552695-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-20552695-ghrp-2-v1
- Content SHA-256: `dce3e60578aa035db0973a0551076856af9f61af66c7b4cab37dae11b6efa50d`

### Claims and source pins

#### Headline

Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. ([`pubmed-observation-pmid-20552695-2019-12-10-2f20509d251c`](#source-pubmed-observation-pmid-20552695-2019-12-10-2f20509d251c))

#### Summary

PubMed lists PMID 20552695 in Rapid communications in mass spectrometry : RCM as Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-07-30 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20552695-2019-12-10-2f20509d251c`](#source-pubmed-observation-pmid-20552695-2019-12-10-2f20509d251c))

#### Paragraph 1

PubMed lists PMID 20552695 in Rapid communications in mass spectrometry : RCM as Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-07-30 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20552695-2019-12-10-2f20509d251c`](#source-pubmed-observation-pmid-20552695-2019-12-10-2f20509d251c))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-20552695-2019-12-10-2f20509d251c`](#source-pubmed-observation-pmid-20552695-2019-12-10-2f20509d251c))

### Sources

<a id="source-pubmed-observation-pmid-20552695-2019-12-10-2f20509d251c"></a>
- **Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. · retained source version 1:2019-12-10:current:2f20509d251c8cf224d29575b1d9deb6a0bda60c01984c945105297610594518** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/20552695/) (`pubmed-observation-pmid-20552695-2019-12-10-2f20509d251c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-20552695-ghrp-2-v1 SHA-256: dce3e60578aa035db0973a0551076856af9f61af66c7b4cab37dae11b6efa50d.

---

<a id="pubmed-pmid-20878896-ghrp-2-v1"></a>

## Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement.

> PubMed lists PMID 20878896 in Drug testing and analysis as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-03 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-20878896-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-11-25
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-20878896-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-20878896-ghrp-2-v1
- Content SHA-256: `a43f277636c5a381d965f5664f777a4d1e60de603a12d60c2971f979254850e5`

### Claims and source pins

#### Headline

Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. ([`pubmed-observation-pmid-20878896-2016-11-25-35e8e7faf59c`](#source-pubmed-observation-pmid-20878896-2016-11-25-35e8e7faf59c))

#### Summary

PubMed lists PMID 20878896 in Drug testing and analysis as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-03 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20878896-2016-11-25-35e8e7faf59c`](#source-pubmed-observation-pmid-20878896-2016-11-25-35e8e7faf59c))

#### Paragraph 1

PubMed lists PMID 20878896 in Drug testing and analysis as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-03 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20878896-2016-11-25-35e8e7faf59c`](#source-pubmed-observation-pmid-20878896-2016-11-25-35e8e7faf59c))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-20878896-2016-11-25-35e8e7faf59c`](#source-pubmed-observation-pmid-20878896-2016-11-25-35e8e7faf59c))

### Sources

<a id="source-pubmed-observation-pmid-20878896-2016-11-25-35e8e7faf59c"></a>
- **Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. · retained source version 1:2016-11-25:current:35e8e7faf59cc76eb467fed0a66deb73c63df2f9a5ce1ef902789285ec25c687** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/20878896/) (`pubmed-observation-pmid-20878896-2016-11-25-35e8e7faf59c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-20878896-ghrp-2-v1 SHA-256: a43f277636c5a381d965f5664f777a4d1e60de603a12d60c2971f979254850e5.

---

<a id="pubmed-pmid-24446112-ghrp-2-v1"></a>

## Identification and quantification of the doping agent GHRP-2 in seized unlabelled vials by NMR and MS: a case-report.

> PubMed lists PMID 24446112 in Drug testing and analysis as Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-01-20 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-24446112-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-12-10
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-24446112-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-24446112-ghrp-2-v1
- Content SHA-256: `250490ae52d76f880719067e97c52401bb1ac0e3676156b91d1dd2c11d6ffc99`

### Claims and source pins

#### Headline

Identification and quantification of the doping agent GHRP-2 in seized unlabelled vials by NMR and MS: a case-report. ([`pubmed-observation-pmid-24446112-2019-12-10-3b38f2090b30`](#source-pubmed-observation-pmid-24446112-2019-12-10-3b38f2090b30))

#### Summary

PubMed lists PMID 24446112 in Drug testing and analysis as Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-01-20 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24446112-2019-12-10-3b38f2090b30`](#source-pubmed-observation-pmid-24446112-2019-12-10-3b38f2090b30))

#### Paragraph 1

PubMed lists PMID 24446112 in Drug testing and analysis as Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-01-20 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24446112-2019-12-10-3b38f2090b30`](#source-pubmed-observation-pmid-24446112-2019-12-10-3b38f2090b30))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-24446112-2019-12-10-3b38f2090b30`](#source-pubmed-observation-pmid-24446112-2019-12-10-3b38f2090b30))

### Sources

<a id="source-pubmed-observation-pmid-24446112-2019-12-10-3b38f2090b30"></a>
- **Identification and quantification of the doping agent GHRP-2 in seized unlabelled vials by NMR and MS: a case-report. · retained source version 1:2019-12-10:current:3b38f2090b3039b886fb23f88de7106a699a745dfffc85f21a6b05f4cf983bb5** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/24446112/) (`pubmed-observation-pmid-24446112-2019-12-10-3b38f2090b30`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Identification and quantification of the doping agent GHRP-2 in seized unlabelled vials by NMR and MS: a case-report." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-24446112-ghrp-2-v1 SHA-256: 250490ae52d76f880719067e97c52401bb1ac0e3676156b91d1dd2c11d6ffc99.

---

<a id="pubmed-pmid-25761386-ghrp-2-v1"></a>

## Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity.

> PubMed lists PMID 25761386 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2015-03-12 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-25761386-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-02
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25761386-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-25761386-ghrp-2-v1
- Content SHA-256: `bed9a1c86a9c665709c9f134685bf6e5a6a6907ec01d7827cc91a68aa66f8814`

### Claims and source pins

#### Headline

Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity. ([`pubmed-observation-pmid-25761386-2018-12-02-b75ba4cddc5e`](#source-pubmed-observation-pmid-25761386-2018-12-02-b75ba4cddc5e))

#### Summary

PubMed lists PMID 25761386 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2015-03-12 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25761386-2018-12-02-b75ba4cddc5e`](#source-pubmed-observation-pmid-25761386-2018-12-02-b75ba4cddc5e))

#### Paragraph 1

PubMed lists PMID 25761386 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2015-03-12 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25761386-2018-12-02-b75ba4cddc5e`](#source-pubmed-observation-pmid-25761386-2018-12-02-b75ba4cddc5e))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25761386-2018-12-02-b75ba4cddc5e`](#source-pubmed-observation-pmid-25761386-2018-12-02-b75ba4cddc5e))

### Sources

<a id="source-pubmed-observation-pmid-25761386-2018-12-02-b75ba4cddc5e"></a>
- **Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity. · retained source version 1:2018-12-02:current:b75ba4cddc5ea741f4d546fd17f8d769c016d487d5335730bbb3ff487dbeb35d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25761386/) (`pubmed-observation-pmid-25761386-2018-12-02-b75ba4cddc5e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-25761386-ghrp-2-v1 SHA-256: bed9a1c86a9c665709c9f134685bf6e5a6a6907ec01d7827cc91a68aa66f8814.

---

<a id="pubmed-pmid-25809000-ghrp-2-v1"></a>

## Detection of GHRP-2 and GHRP-6 in urine samples from athletes.

> PubMed lists PMID 25809000 in Drug testing and analysis as Journal Article, with publication-date metadata of 2015-03-25 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-25809000-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-11-25
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25809000-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-25809000-ghrp-2-v1
- Content SHA-256: `cf590c848cdf61eb6fea959f449dc7a4130717cf5d3462af82c1e975e8e89528`

### Claims and source pins

#### Headline

Detection of GHRP-2 and GHRP-6 in urine samples from athletes. ([`pubmed-observation-pmid-25809000-2016-11-25-88756a2953f2`](#source-pubmed-observation-pmid-25809000-2016-11-25-88756a2953f2))

#### Summary

PubMed lists PMID 25809000 in Drug testing and analysis as Journal Article, with publication-date metadata of 2015-03-25 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25809000-2016-11-25-88756a2953f2`](#source-pubmed-observation-pmid-25809000-2016-11-25-88756a2953f2))

#### Paragraph 1

PubMed lists PMID 25809000 in Drug testing and analysis as Journal Article, with publication-date metadata of 2015-03-25 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25809000-2016-11-25-88756a2953f2`](#source-pubmed-observation-pmid-25809000-2016-11-25-88756a2953f2))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25809000-2016-11-25-88756a2953f2`](#source-pubmed-observation-pmid-25809000-2016-11-25-88756a2953f2))

### Sources

<a id="source-pubmed-observation-pmid-25809000-2016-11-25-88756a2953f2"></a>
- **Detection of GHRP-2 and GHRP-6 in urine samples from athletes. · retained source version 1:2016-11-25:current:88756a2953f2139bcc8b09dd7bc75ef9265762493d1aa987378d6e19ab573e7c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25809000/) (`pubmed-observation-pmid-25809000-2016-11-25-88756a2953f2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Detection of GHRP-2 and GHRP-6 in urine samples from athletes." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-25809000-ghrp-2-v1 SHA-256: cf590c848cdf61eb6fea959f449dc7a4130717cf5d3462af82c1e975e8e89528.

---

<a id="pubmed-pmid-27020037-ghrp-2-v1"></a>

## Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure.

> PubMed lists PMID 27020037 in Endocrine journal as Controlled Clinical Trial, Journal Article, with publication-date metadata of 2016-03-26 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-27020037-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-03-21
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27020037-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-27020037-ghrp-2-v1
- Content SHA-256: `c2d4c3479a0877962bda658cbdc5e8313fb35ebd530dc0365a59336f645bac8c`

### Claims and source pins

#### Headline

Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure. ([`pubmed-observation-pmid-27020037-2022-03-21-822ad5fc3e5b`](#source-pubmed-observation-pmid-27020037-2022-03-21-822ad5fc3e5b))

#### Summary

PubMed lists PMID 27020037 in Endocrine journal as Controlled Clinical Trial, Journal Article, with publication-date metadata of 2016-03-26 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27020037-2022-03-21-822ad5fc3e5b`](#source-pubmed-observation-pmid-27020037-2022-03-21-822ad5fc3e5b))

#### Paragraph 1

PubMed lists PMID 27020037 in Endocrine journal as Controlled Clinical Trial, Journal Article, with publication-date metadata of 2016-03-26 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27020037-2022-03-21-822ad5fc3e5b`](#source-pubmed-observation-pmid-27020037-2022-03-21-822ad5fc3e5b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27020037-2022-03-21-822ad5fc3e5b`](#source-pubmed-observation-pmid-27020037-2022-03-21-822ad5fc3e5b))

### Sources

<a id="source-pubmed-observation-pmid-27020037-2022-03-21-822ad5fc3e5b"></a>
- **Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure. · retained source version 1:2022-03-21:current:822ad5fc3e5b910da0554557d1db2a9136d01f8baf73cf788214322dc9c0e795** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27020037/) (`pubmed-observation-pmid-27020037-2022-03-21-822ad5fc3e5b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-27020037-ghrp-2-v1 SHA-256: c2d4c3479a0877962bda658cbdc5e8313fb35ebd530dc0365a59336f645bac8c.

---

<a id="pubmed-pmid-33197153-ghrp-2-v1"></a>

## On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse.

> PubMed lists PMID 33197153 in Drug testing and analysis as Journal Article, Validation Study, with publication-date metadata of 2020-11-25 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-33197153-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-10-28
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-33197153-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-33197153-ghrp-2-v1
- Content SHA-256: `41e80b4dd64f373fd5dcee9cdc2ca044201666b9f983173798e9b0a5e7338bb2`

### Claims and source pins

#### Headline

On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse. ([`pubmed-observation-pmid-33197153-2021-10-28-21d77567dd0c`](#source-pubmed-observation-pmid-33197153-2021-10-28-21d77567dd0c))

#### Summary

PubMed lists PMID 33197153 in Drug testing and analysis as Journal Article, Validation Study, with publication-date metadata of 2020-11-25 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33197153-2021-10-28-21d77567dd0c`](#source-pubmed-observation-pmid-33197153-2021-10-28-21d77567dd0c))

#### Paragraph 1

PubMed lists PMID 33197153 in Drug testing and analysis as Journal Article, Validation Study, with publication-date metadata of 2020-11-25 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33197153-2021-10-28-21d77567dd0c`](#source-pubmed-observation-pmid-33197153-2021-10-28-21d77567dd0c))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-33197153-2021-10-28-21d77567dd0c`](#source-pubmed-observation-pmid-33197153-2021-10-28-21d77567dd0c))

### Sources

<a id="source-pubmed-observation-pmid-33197153-2021-10-28-21d77567dd0c"></a>
- **On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse. · retained source version 1:2021-10-28:current:21d77567dd0c4ac4c0e528b19357a145a74d440d385b530fd7b52c85a3b9e41e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/33197153/) (`pubmed-observation-pmid-33197153-2021-10-28-21d77567dd0c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-33197153-ghrp-2-v1 SHA-256: 41e80b4dd64f373fd5dcee9cdc2ca044201666b9f983173798e9b0a5e7338bb2.

---

<a id="pubmed-pmid-35795807-ghrp-2-v1"></a>

## Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder.

> PubMed lists PMID 35795807 in Journal of the Endocrine Society as Journal Article, with publication-date metadata of 2022-06-06 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-35795807-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-07-16
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-35795807-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-35795807-ghrp-2-v1
- Content SHA-256: `3f664e4d1e2a9c7c239bc8962ee85c98c9a81a521d2bceb0d1ed544a5395785a`

### Claims and source pins

#### Headline

Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder. ([`pubmed-observation-pmid-35795807-2022-07-16-3a0c19e61e25`](#source-pubmed-observation-pmid-35795807-2022-07-16-3a0c19e61e25))

#### Summary

PubMed lists PMID 35795807 in Journal of the Endocrine Society as Journal Article, with publication-date metadata of 2022-06-06 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35795807-2022-07-16-3a0c19e61e25`](#source-pubmed-observation-pmid-35795807-2022-07-16-3a0c19e61e25))

#### Paragraph 1

PubMed lists PMID 35795807 in Journal of the Endocrine Society as Journal Article, with publication-date metadata of 2022-06-06 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35795807-2022-07-16-3a0c19e61e25`](#source-pubmed-observation-pmid-35795807-2022-07-16-3a0c19e61e25))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-35795807-2022-07-16-3a0c19e61e25`](#source-pubmed-observation-pmid-35795807-2022-07-16-3a0c19e61e25))

### Sources

<a id="source-pubmed-observation-pmid-35795807-2022-07-16-3a0c19e61e25"></a>
- **Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder. · retained source version 1:2022-07-16:current:3a0c19e61e25d886838b0441d9e10e3d9c6b4852662a8ac01c9a859a4b6eeb0e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/35795807/) (`pubmed-observation-pmid-35795807-2022-07-16-3a0c19e61e25`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-35795807-ghrp-2-v1 SHA-256: 3f664e4d1e2a9c7c239bc8962ee85c98c9a81a521d2bceb0d1ed544a5395785a.

---

<a id="pubmed-pmid-8886623-ghrp-2-v1"></a>

## Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves.

> PubMed lists PMID 8886623 in Endocrine journal as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1996-06 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-8886623-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-09-05
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-8886623-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-8886623-ghrp-2-v1
- Content SHA-256: `995c8d69f63d32b171154ab6305cdb14b232845407f4c8ec3a9c3eece39754a1`

### Claims and source pins

#### Headline

Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves. ([`pubmed-observation-pmid-8886623-2019-09-05-0ef27668c5f6`](#source-pubmed-observation-pmid-8886623-2019-09-05-0ef27668c5f6))

#### Summary

PubMed lists PMID 8886623 in Endocrine journal as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1996-06 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8886623-2019-09-05-0ef27668c5f6`](#source-pubmed-observation-pmid-8886623-2019-09-05-0ef27668c5f6))

#### Paragraph 1

PubMed lists PMID 8886623 in Endocrine journal as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1996-06 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8886623-2019-09-05-0ef27668c5f6`](#source-pubmed-observation-pmid-8886623-2019-09-05-0ef27668c5f6))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-8886623-2019-09-05-0ef27668c5f6`](#source-pubmed-observation-pmid-8886623-2019-09-05-0ef27668c5f6))

### Sources

<a id="source-pubmed-observation-pmid-8886623-2019-09-05-0ef27668c5f6"></a>
- **Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves. · retained source version 1:2019-09-05:current:0ef27668c5f6d667d63f4b43755ccbda2ec80b1bf8a9df39292bf73f9b3c59ad** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/8886623/) (`pubmed-observation-pmid-8886623-2019-09-05-0ef27668c5f6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-8886623-ghrp-2-v1 SHA-256: 995c8d69f63d32b171154ab6305cdb14b232845407f4c8ec3a9c3eece39754a1.

---

<a id="pubmed-pmid-9096259-ghrp-2-v1"></a>

## Growth hormone releasing peptides: a comparison of the growth hormone releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary cells.

> PubMed lists PMID 9096259 in Life sciences as Comparative Study, Journal Article, with publication-date metadata of 1997 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-9096259-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-07-01
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9096259-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-9096259-ghrp-2-v1
- Content SHA-256: `3b7acbab3736df8561e63b7de4c6c9c36120174b23f64cd81ba9d2120821fe32`

### Claims and source pins

#### Headline

Growth hormone releasing peptides: a comparison of the growth hormone releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary cells. ([`pubmed-observation-pmid-9096259-2019-07-01-9eee0b05fe29`](#source-pubmed-observation-pmid-9096259-2019-07-01-9eee0b05fe29))

#### Summary

PubMed lists PMID 9096259 in Life sciences as Comparative Study, Journal Article, with publication-date metadata of 1997 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-9096259-2019-07-01-9eee0b05fe29`](#source-pubmed-observation-pmid-9096259-2019-07-01-9eee0b05fe29))

#### Paragraph 1

PubMed lists PMID 9096259 in Life sciences as Comparative Study, Journal Article, with publication-date metadata of 1997 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-9096259-2019-07-01-9eee0b05fe29`](#source-pubmed-observation-pmid-9096259-2019-07-01-9eee0b05fe29))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9096259-2019-07-01-9eee0b05fe29`](#source-pubmed-observation-pmid-9096259-2019-07-01-9eee0b05fe29))

### Sources

<a id="source-pubmed-observation-pmid-9096259-2019-07-01-9eee0b05fe29"></a>
- **Growth hormone releasing peptides: a comparison of the growth hormone releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary cells. · retained source version 1:2019-07-01:current:9eee0b05fe290549433fb51f411e3cb5df0bebee50c0a7dd4058a47abebc3f8c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9096259/) (`pubmed-observation-pmid-9096259-2019-07-01-9eee0b05fe29`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Growth hormone releasing peptides: a comparison of the growth hormone releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary cells." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-9096259-ghrp-2-v1 SHA-256: 3b7acbab3736df8561e63b7de4c6c9c36120174b23f64cd81ba9d2120821fe32.

---

<a id="pubmed-pmid-9543135-ghrp-2-v1"></a>

## Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children.

> PubMed lists PMID 9543135 in The Journal of clinical endocrinology and metabolism as Clinical Trial, Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1998-04 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-9543135-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-11-24
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9543135-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-9543135-ghrp-2-v1
- Content SHA-256: `2c1fb561d66a979fe0e06603262332e023e911175a5d7b6d59d58302f05442dc`

### Claims and source pins

#### Headline

Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children. ([`pubmed-observation-pmid-9543135-2016-11-24-07dee7513491`](#source-pubmed-observation-pmid-9543135-2016-11-24-07dee7513491))

#### Summary

PubMed lists PMID 9543135 in The Journal of clinical endocrinology and metabolism as Clinical Trial, Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1998-04 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-9543135-2016-11-24-07dee7513491`](#source-pubmed-observation-pmid-9543135-2016-11-24-07dee7513491))

#### Paragraph 1

PubMed lists PMID 9543135 in The Journal of clinical endocrinology and metabolism as Clinical Trial, Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1998-04 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-9543135-2016-11-24-07dee7513491`](#source-pubmed-observation-pmid-9543135-2016-11-24-07dee7513491))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9543135-2016-11-24-07dee7513491`](#source-pubmed-observation-pmid-9543135-2016-11-24-07dee7513491))

### Sources

<a id="source-pubmed-observation-pmid-9543135-2016-11-24-07dee7513491"></a>
- **Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children. · retained source version 1:2016-11-24:current:07dee7513491a421b4e751ed931c73d444f0dfb94727dfc715712ea1f618bec1** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9543135/) (`pubmed-observation-pmid-9543135-2016-11-24-07dee7513491`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-9543135-ghrp-2-v1 SHA-256: 2c1fb561d66a979fe0e06603262332e023e911175a5d7b6d59d58302f05442dc.

---

<a id="pubmed-pmid-9559140-ghrp-2-v1"></a>

## \[Activity of growth hormone-releasing peptide-2 in cultured cells of human pituitary adenoma and its interaction with growth hormone-releasing hormone and somatostatin\].

> PubMed lists PMID 9559140 in Biulleten' eksperimental'noi biologii i meditsiny as Journal Article, with publication-date metadata of 1998-02 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-9559140-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-01
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9559140-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-9559140-ghrp-2-v1
- Content SHA-256: `fef05711f0e733d7445a68420251118cb04038cb1cf4ffb90dfedb2f12b6f688`

### Claims and source pins

#### Headline

\[Activity of growth hormone-releasing peptide-2 in cultured cells of human pituitary adenoma and its interaction with growth hormone-releasing hormone and somatostatin\]. ([`pubmed-observation-pmid-9559140-2018-12-01-d071eaf18df9`](#source-pubmed-observation-pmid-9559140-2018-12-01-d071eaf18df9))

#### Summary

PubMed lists PMID 9559140 in Biulleten' eksperimental'noi biologii i meditsiny as Journal Article, with publication-date metadata of 1998-02 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-9559140-2018-12-01-d071eaf18df9`](#source-pubmed-observation-pmid-9559140-2018-12-01-d071eaf18df9))

#### Paragraph 1

PubMed lists PMID 9559140 in Biulleten' eksperimental'noi biologii i meditsiny as Journal Article, with publication-date metadata of 1998-02 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-9559140-2018-12-01-d071eaf18df9`](#source-pubmed-observation-pmid-9559140-2018-12-01-d071eaf18df9))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9559140-2018-12-01-d071eaf18df9`](#source-pubmed-observation-pmid-9559140-2018-12-01-d071eaf18df9))

### Sources

<a id="source-pubmed-observation-pmid-9559140-2018-12-01-d071eaf18df9"></a>
- **\[Activity of growth hormone-releasing peptide-2 in cultured cells of human pituitary adenoma and its interaction with growth hormone-releasing hormone and somatostatin\]. · retained source version 1:2018-12-01:current:d071eaf18df9213adbc7a9f488fa15e18c93c27b1d8422c6aac373af4abe6197** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9559140/) (`pubmed-observation-pmid-9559140-2018-12-01-d071eaf18df9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "\[Activity of growth hormone-releasing peptide-2 in cultured cells of human pituitary adenoma and its interaction with growth hormone-releasing hormone and somatostatin\]." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-9559140-ghrp-2-v1 SHA-256: fef05711f0e733d7445a68420251118cb04038cb1cf4ffb90dfedb2f12b6f688.

---

<a id="pubmed-pmid-9798733-ghrp-2-v1"></a>

## Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells.

> PubMed lists PMID 9798733 in Endocrine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1998-08 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-9798733-ghrp-2:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-07-16
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9798733-ghrp-2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-9798733-ghrp-2-v1
- Content SHA-256: `df2ae6d50e3bd60d5a9da6c13993d1fadb8842da0efee1b294a297b1984ca375`

### Claims and source pins

#### Headline

Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells. ([`pubmed-observation-pmid-9798733-2022-07-16-2fee9986283e`](#source-pubmed-observation-pmid-9798733-2022-07-16-2fee9986283e))

#### Summary

PubMed lists PMID 9798733 in Endocrine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1998-08 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-9798733-2022-07-16-2fee9986283e`](#source-pubmed-observation-pmid-9798733-2022-07-16-2fee9986283e))

#### Paragraph 1

PubMed lists PMID 9798733 in Endocrine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1998-08 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-9798733-2022-07-16-2fee9986283e`](#source-pubmed-observation-pmid-9798733-2022-07-16-2fee9986283e))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9798733-2022-07-16-2fee9986283e`](#source-pubmed-observation-pmid-9798733-2022-07-16-2fee9986283e))

### Sources

<a id="source-pubmed-observation-pmid-9798733-2022-07-16-2fee9986283e"></a>
- **Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells. · retained source version 1:2022-07-16:current:2fee9986283ef10a157f2ebb1bb2801e822b8497af1c8e5666500728c4a7c96c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9798733/) (`pubmed-observation-pmid-9798733-2022-07-16-2fee9986283e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ghrp-2.json#pubmed-pmid-9798733-ghrp-2-v1 SHA-256: df2ae6d50e3bd60d5a9da6c13993d1fadb8842da0efee1b294a297b1984ca375.

